Pennantpark Investment
PNNT · NYSE
About PNNT
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Apr 19, 2007
- Sector
- Financials
- Industry
- Capital Markets
- Website
- pennantpark.com
PNNT key statistics
- Market cap
- 188.05M
- Price-earnings ratio
- 19.40
- Dividend yield
- 32.76%
- Average volume
- 524.56K
- Volume
- 605.36K
- Open price
- $2.92
- High today
- $2.97
- Low today
- $2.88
- 52 Week high
- $6.67
- 52 Week low
- $2.91
Pennantpark Investment (PNNT) at a glance
As of Oct 20, 2026, Pennantpark Investment (PNNT) shares are priced at $2.88, giving the company a market cap of 188.05M, a price-to-earnings ratio of 19.40 and a dividend yield of 32.76%.
Today the stock has traded between $2.88 and $2.97. The current price is 0.0% above the day's low and 3.0% below its high.
Volume so far is 605.36K shares, in line with the average of 524.56K shares a day.
Over the past year Pennantpark Investment has ranged from $2.91 to $6.67, and now sits -1% of the way up that range.
Pennantpark Investment met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported $0.14 per share against an estimate of $0.1421.
The average analyst price target is $5.00, 73.5% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy20.0%
- Hold60.0%
- Sell20.0%
- Low
- $4.04
- Now
- $2.88
- High
- $5.78
PNNT earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 7.6% on average.
- Q3 FY24: reported $0.25 per share against an estimate of $0.2323
- Q4 FY24: reported $0.22 per share against an estimate of $0.2243
- Q1 FY25: reported $0.20 per share against an estimate of $0.2157
- Q2 FY25: reported $0.18 per share against an estimate of $0.1954
- Q3 FY25: reported $0.18 per share against an estimate of $0.1862
- Q4 FY25: reported $0.15 per share against an estimate of $0.1777
- Q1 FY26: reported $0.14 per share against an estimate of $0.1503
- Q2 FY26: reported $0.14 per share against an estimate of $0.1421
PNNT news
- Avi Kapoor
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields
Examining the Future: Pennant Park Investment's Earnings Outlook
A Look Ahead: Pennant Park Investment's Earnings Forecast
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 15% Dividend Yields
Pennant Park Investment's Earnings: A Preview
Similar companies
Companies in the same industry as Pennantpark Investment
- SARSaratoga Investment$14.21−4.63%
- SPMCSound Point Meridian Capital$6.19−8.21%
- LIENChicago Atlantic BDC$9.10+0.55%
- BANXArrowMark Financial$19.99+1.68%
- SCMStellus Capital Investment$6.83−2.01%
- WHGWestwood Holdings Group$18.74+0.00%
- TPVGTriplePoint Venture Growth BDC$4.29−2.05%
- EARNEllington Credit$3.56+1.14%
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.